Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Potential of Artificial Intelligence for Earlier Breast Cancer Detection: A Retrospective Multi-Reader Study Based on AI-Assisted Mammographic Interpretation (EARLIEST-AI)

NCT07556900 is registered in ClinicalTrials.gov with Mammograaf Radioloogiakliinik as lead sponsor.

NCT NCT07556900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07556900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Potential of Artificial Intelligence for Earlier Breast Cancer Detection: A Retrospective Multi-Reader Study Based on AI-Assisted Mammographic Interpretation (EARLIEST-AI)
Lead sponsor
Mammograaf Radioloogiakliinik
Phase
Observational
Overall status
Active, not recruiting
Start date
October 1, 2025
Completion date
September 30, 2026
Enrollment
785 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ai (artificial intelligence), breast cancer, early detection of cancer